News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dyax Corp. (DYAX) and FivePrime Therapeutics, Inc. Enter Into Research Agreement for Discovery of Therapeutic Antibodies


4/27/2011 10:53:03 AM

CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) and Five Prime Therapeutics, Inc. (FivePrime) announced today that they have entered into an antibody funded research agreement for the discovery of therapeutic antibodies.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES